子宫内膜异位症相关性卵巢癌的研究进展  

Progress of endometriosis-related ovarian cancer

作　　者：魏巧红 武晓红[2] Wei Qiaohong;Wu Xiaohong(Graduate School of Shanxi Medical University,Taiyuan 030001,China;Department of Gynecology 2,Shanxi Province Cancer Hospital,Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences,Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan 030013,China)

机构地区：[1]山西医科大学研究生学院,太原030001 [2]山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院妇二科,太原030013

出　　处：《肿瘤研究与临床》2022年第3期227-230,共4页Cancer Research and Clinic

摘　　要：子宫内膜异位症(EM)作为妇科常见的良性疾病之一,可对育龄期女性的身心健康和生命质量产生严重的影响。研究表明,EM患者患卵巢癌的风险较普通人群明显升高,EM与部分卵巢癌的发生有着密切的关系,并将这类卵巢癌命名为子宫内膜异位症相关性卵巢癌(EAOC)。文章就EAOC的发病率、发病机制、治疗及预后等相关问题进行综述,以期更好地了解EAOC。As one of the common benign gynecological diseases,endometriosis(EM)can have a serious impact on the physical and mental health and quality of life of women of childbearing age.Studies have shown that the risk of ovarian cancer in patients with EM is significantly higher than that in the general population.EM is closely related to the occurrence of some types of ovarian cancer,and this kind of ovarian cancer is named endometriosis-related ovarian cancer(EAOC).The incidence rate,pathogenesis,treatment and prognosis of EAOC are summarized in order to better understand it.

关 键 词：子宫内膜异位症 卵巢肿瘤 激素受体 分子标志物 

分 类 号：R711.71[医药卫生—妇产科学] R737.31[医药卫生—临床医学]